These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11257507)

  • 1. Active site structure of the catalase-peroxidases from Mycobacterium tuberculosis and Escherichia coli by extended X-ray absorption fine structure analysis.
    Powers L; Hillar A; Loewen PC
    Biochim Biophys Acta; 2001 Mar; 1546(1):44-54. PubMed ID: 11257507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the activities of catalase-peroxidase HPI of Escherichia coli by site-directed mutagenesis.
    Hillar A; Peters B; Pauls R; Loboda A; Zhang H; Mauk AG; Loewen PC
    Biochemistry; 2000 May; 39(19):5868-75. PubMed ID: 10801338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.
    Kapetanaki S; Chouchane S; Girotto S; Yu S; Magliozzo RS; Schelvis JP
    Biochemistry; 2003 Apr; 42(13):3835-45. PubMed ID: 12667074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tuberculosis prodrug isoniazid bound to activating peroxidases.
    Metcalfe C; Macdonald IK; Murphy EJ; Brown KA; Raven EL; Moody PC
    J Biol Chem; 2008 Mar; 283(10):6193-200. PubMed ID: 18056997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function.
    Kapetanaki SM; Chouchane S; Yu S; Zhao X; Magliozzo RS; Schelvis JP
    Biochemistry; 2005 Jan; 44(1):243-52. PubMed ID: 15628865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942.
    Kamachi S; Hirabayashi K; Tamoi M; Shigeoka S; Tada T; Wada K
    FEBS J; 2015 Jan; 282(1):54-64. PubMed ID: 25303560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the active site of Mycobacterium tuberculosis KatG after disruption of the Met-Tyr-Trp cross-linked adduct.
    Kapetanaki SM; Zhao X; Yu S; Magliozzo RS; Schelvis JP
    J Inorg Biochem; 2007 Mar; 101(3):422-33. PubMed ID: 17188362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid formation of compound II and a tyrosyl radical in the Y229F mutant of Mycobacterium tuberculosis catalase-peroxidase disrupts catalase but not peroxidase function.
    Yu S; Girotto S; Zhao X; Magliozzo RS
    J Biol Chem; 2003 Nov; 278(45):44121-7. PubMed ID: 12944408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two [Fe(IV)=O Trp*] intermediates in M. tuberculosis catalase-peroxidase discriminated by multifrequency (9-285 GHz) EPR spectroscopy: reactivity toward isoniazid.
    Singh R; Switala J; Loewen PC; Ivancich A
    J Am Chem Soc; 2007 Dec; 129(51):15954-63. PubMed ID: 18052167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of distal side water and residue 315 on ligand binding to ferric Mycobacterium tuberculosis catalase-peroxidase (KatG).
    Ranguelova K; Suarez J; Metlitsky L; Yu S; Brejt SZ; Brejt SZ; Zhao L; Schelvis JP; Magliozzo RS
    Biochemistry; 2008 Nov; 47(47):12583-92. PubMed ID: 18956888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-based radicals in the catalase-peroxidase of synechocystis PCC6803: a multifrequency EPR investigation of wild-type and variants on the environment of the heme active site.
    Ivancich A; Jakopitsch C; Auer M; Un S; Obinger C
    J Am Chem Soc; 2003 Nov; 125(46):14093-102. PubMed ID: 14611246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid.
    Wengenack NL; Uhl JR; St Amand AL; Tomlinson AJ; Benson LM; Naylor S; Kline BC; Cockerill FR; Rusnak F
    J Infect Dis; 1997 Sep; 176(3):722-7. PubMed ID: 9291321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of heme structural heterogeneity in Mycobacterium tuberculosis catalase-peroxidase (KatG).
    Chouchane S; Girotto S; Kapetanaki S; Schelvis JP; Yu S; Magliozzo RS
    J Biol Chem; 2003 Mar; 278(10):8154-62. PubMed ID: 12506108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal site aspartate is essential in the catalase activity of catalase-peroxidases.
    Jakopitsch C; Auer M; Regelsberger G; Jantschko W; Furtmüller PG; Rüker F; Obinger C
    Biochemistry; 2003 May; 42(18):5292-300. PubMed ID: 12731870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.
    Heym B; Zhang Y; Poulet S; Young D; Cole ST
    J Bacteriol; 1993 Jul; 175(13):4255-9. PubMed ID: 8320241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oxyferrous heme/protein-based radical intermediate is catalytically competent in the catalase reaction of Mycobacterium tuberculosis catalase-peroxidase (KatG).
    Suarez J; Ranguelova K; Jarzecki AA; Manzerova J; Krymov V; Zhao X; Yu S; Metlitsky L; Gerfen GJ; Magliozzo RS
    J Biol Chem; 2009 Mar; 284(11):7017-29. PubMed ID: 19139099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.
    Mo L; Zhang W; Wang J; Weng XH; Chen S; Shao LY; Pang MY; Chen ZW
    Microb Drug Resist; 2004; 10(4):269-79. PubMed ID: 15650370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation.
    Chouchane S; Lippai I; Magliozzo RS
    Biochemistry; 2000 Aug; 39(32):9975-83. PubMed ID: 10933818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis.
    Johnsson K; Froland WA; Schultz PG
    J Biol Chem; 1997 Jan; 272(5):2834-40. PubMed ID: 9006925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).
    Wengenack NL; Todorovic S; Yu L; Rusnak F
    Biochemistry; 1998 Nov; 37(45):15825-34. PubMed ID: 9843388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.